Biogenic fabrication and enhanced photocatalytic degradation of tetracycline by bio structured ZnO nanoparticles

Abstract

Zinc oxide nanoparticles (ZnO NPs) were synthesized using Zinc Nitrate as precursor salt, and plant leaves extracts from Azadirachta indica (Common name: Neem), Cymbopogan citratus (Common name: Lemongrass), and Mangifera indica (Common name: Mango), as both chelating and reducing agents for the synthesis of ZnO NPs by a simple cost-effective and eco-friendly green method. The biosynthesized ZnO NPs were well characterized by various methods. XRD pattern revealed a hexagonal wurtzite phase of ZnO, with no other impurity peaks present revealing XRD crystalline sizes of 13.94-16.37 nm calculated using Scherrer equation. The XPS confirmed the presence of Zn, O, and C, and the carbon peaks are almost in agreement with peaks observed by FT-IR. TEM showed the different ZnO with spherical shapes and some aggregations. BET surface area gave 24.98, 21.62, and 22.72 m2/g, respectively for ZnO-AI, ZnO-Cyc, and ZnO-MI, while BJH pore volume and average pore diameter were estimated to be 0.217 cc/g, 0.209 cc/g, 0.211 cc/g, and 2.132 nm, 2.025 nm, and 2.100 nm respectively for ZnO-AI, ZnO-Cyc, and ZnO-MI. Furthermore, the bio-synthesized ZnO NPs were evaluated for their catalytic and photocatalytic performance in the degradation of aqueous tetracycline (TC). The biosynthesized ZnO NPs exhibit good photodegradation efficiency for TC in varying degrees with ZnO-AI > ZnO-MI > ZnO-Cyc. Optimum operational parameters for TC degradation using the ZnO-AI were established, and maximum degradation efficiency of 84.8% was obtained. In addition, the catalyst can also be regenerated and reused up to three cycles, with the third cycle still achieving greater than 80% TC degradation.